Updated studies may move breast cancer drug to first-line treatment
September 17th 2007A 300-patient, randomized phase II study showed that weekly treatment of metastatic breast cancer with solvent-free, aluminum-bound nab-paclitaxel is better tolerated than standard first-line treatment with docetaxel.
Many hospitals are still noncompliant on medication reconciliation
September 17th 2007A recent Institute for Safe Medication Practices teleconference with a surveyor from The Joint Commission highlighted the rigor with which TJC is implementing its medication management standards and National Patient Safety Goals.